Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

P&G Likely To Keep Prilosec OTC, Vicks In Portfolio Shuffle – Analysts

This article was originally published in The Pink Sheet Daily

Executive Summary

P&G’s plan to sell half of its brands triggered speculation about what the firm will keep and what it will sell. A Bernstein analyst predicts the firm will part with many oral care products and dietary supplements, but will keep consumer health brands including Prilosec OTC, Vicks and Crest.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS077728

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel